Corkery, D P <br/><br/>
Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking.  [electronic resource] 

 -  Oncogene  01 2018 
 - 174-184 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2017.318  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anoikis--genetics<br/>Biomarkers, Tumor--deficiency<br/>Breast Neoplasms--pathology<br/>Cell Line, Tumor<br/>Cell Nucleus--metabolism<br/>Down-Regulation<br/>Endosomes--metabolism<br/>Epidermal Growth Factor--metabolism<br/>Epithelial Cells--cytology<br/>ErbB Receptors--metabolism<br/>Female<br/>Humans<br/>Lung Neoplasms--pathology<br/>Mice<br/>Mice, Inbred C57BL<br/>Neoplasm Invasiveness--pathology<br/>Ovarian Neoplasms--pathology<br/>Protein Serine-Threonine Kinases--deficiency<br/>RNA, Small Interfering--metabolism<br/>Ribonucleoprotein, U4-U6 Small Nuclear--deficiency<br/>Signal Transduction--genetics<br/>Xenograft Model Antitumor Assays<br/>Zebrafish